Introduction of Cyramza 100 mg Injection

• Cyramza 100 mg Injection is a monoclonal antibody medication used in cancer treatment. Cyramza 100 mg works by blocking the activity of a protein called vascular endothelial growth factor receptor 2 (VEGFR2), which plays a role in the growth of blood vessels that supply tumours. By inhibiting this protein, ramucirumab can help slow down or stop the growth of cancer cells.

  There are several common side effects associated with the use of Cyramza Injection. One of the most common side effects is high blood pressure. Your doctor needs to check your blood pressure regularly while you are taking this medicine. It is also important to stay well hydrated as this medicine can also cause diarrhoea and headaches. Another possible effect is a decrease in the number of red blood cells in your blood, so you will need regular blood tests to monitor your blood cell counts throughout your treatment with Cyramza 100 mg.

  Avoid and tell your doctor if you are allergic to Cyramza 100 mg or any of its ingredients. Inform your doctor if you have a history of cardiovascular disease, heart attack, stroke, high blood pressure, planned surgery, lung problems or liver/kidney disease as it may cause adverse effects. Cyramza 100 mg Injection is known to cause embryo-fetal toxicity, so if you are pregnant or breastfeeding, tell your doctor beforehand.

  Cyramza 100 mg Injection is given by a trained healthcare professional through an infusion. Your doctor will prescribe the correct dose and frequency depending on your condition. It is important to follow your doctor's instructions carefully to avoid any possible adverse effects. Although it may take some time to feel the benefits of this medicine, do not stop taking it unless advised to do so by your doctor.
  

Uses of Cyramza 100 mg Injection

• • Stomach cancer
  • Colorectal cancer
  • Non-small cell lung cancer
  • Hepatocellular carcinoma(Liver cancer)
    

Benefits of Cyramza 100 mg Injection

• Gastric cancer: Gastric Cancer: Cyramza 100 mg Injection may be used alone or in combination with other chemotherapy drugs to treat advanced gastric (stomach) cancer or gastroesophageal junction (GEJ) cancer. Cyramza 100 mg can help slow down disease progression and improve overall survival in patients with these types of cancer.

  Colorectal cancer: Cyramza 100 mg Injection may be used with other chemotherapy medicines to treat metastatic colorectal cancer that has progressed after prior therapy. Cyramza Injection can delay tumor growth and extend survival in these patients.

  Non-small cell lung cancer: Cyramza 100 mg Injection is prescribed for patients with advanced NSCLC, particularly those with certain molecular characteristics. Cyramza 100 mg may be used in combination with other anticancer medications to improve treatment outcomes.

  Hepatocellular carcinoma (Liver Cancer): Cyramza 100 mg Injection is used for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have a serum alpha-fetoprotein (AFP) of ≥ 400 ng/ml and who have been previously treated with sorafenib.
  

Side Effects of Cyramza 100 mg Injection

• Like all medicines, Cyramza 100 mg Injection may cause side effects such as high blood pressure, fatigue, nausea, vomiting, and diarrhoea. Tell your doctor if you have high blood pressure, bleeding problems, liver disease, kidney disease, lung cancer, or are going to have surgery before taking this medication. This medicine is not recommended for adolescents or children under 18 years of age.
  

Most Common Side Effects of Cyramza 100 mg Injection

• • Sore throat
  • Hypertension
  • Nausea
  • Vomiting
  • Diarrhea
  • Headache
  • Chills
  • Fever
  • Fainting
  • Nervousness
  • Shivering
  • Weakness
  • Pounding in ears
  • Seizures

Common Side Effects of Cyramza 100 mg Injection

• • Visual Changes
    
  • Rashes
  • Dry mouth
  • Feeling of Dehydration
  • Decreased Urine
  • Dizziness
  • Loss of Appetite
  • Dry Cough
  • Productive Cough
  • Painful Urination
  • Pale skin
  • Abdominal Cramps
  • Slurred Speech
  • Sweating
  • Blurred Vision
  • feeling of Numbness

How to Use Cyramza 100 mg Injection?

• Cyramza 100 mg Injection should be given under the supervision of your healthcare professional as an infusion directly into a vein or intravenously. The dosage and duration of your medication will depend on many factors such as the severity of your illness, type of illness, age, weight, gender and other medical conditions. It is a good idea to tell your doctor or health care professional about all other medicines you are taking or are being treated with. Avoid using this medicine if you are pregnant or breastfeeding as safety in these patients has not been established.
  

How Cyramza 100 mg Injection Works?

• Cyramza 100 mg Injection is a recombinant monoclonal antibody that inhibits vascular endothelial growth factor receptor 2 (VEGFR2). Ramucirumab has a high affinity for VEGFR2 and blocks binding of the VEGFR ligands, VEGF-A, VEGF-C and VEGF-D, to inhibit activation of VEGFR2 and thereby inhibit ligand-induced proliferation and migration of endothelial cells. VEGFR2 inhibition outcomes in decreased tumour vascularity and growth.
  

Safety Advices Cyramza 100 mg Injection

Liver

Use with Caution

Cyramza 100 mg Injection should be used with extreme caution in patients with liver disease due to the increased risk of worsening the patient's condition. Close monitoring of liver function is essential while taking this medicine. Appropriate dose adjustment or substitution with a suitable alternative may be required in some cases depending on the clinical condition of the patient.

Kidney

Use with Caution

Cyramza 100 mg Injection should be used with extreme caution in patients with kidney disease due to the increased risk of worsening of the patient's condition. Close monitoring of kidney function is essential while taking this Cyramza 100 mg. Appropriate dose adjustment or substitution with a suitable alternative may be required in some cases depending on the clinical condition of the patient.

Alcohol

Unsafe

It is generally recommended that patients taking {Product_namee_two} should avoid or reduce their alcohol intake as alcohol can increase the risk of liver damage and worsen any liver-related side effects of this medicine.

Pregnancy

Unsafe

Cyramza 100 mg Injection is not recommended during pregnancy or in women of childbearing potential who are not using contraception. Women of childbearing potential should be advised not to become pregnant while taking Cyramza Injection and should be counselled about the potential hazards to pregnancy and the foetus. Women of childbearing potential should use effective contraception during and for up to 3 months after the last dose of Cyramza 100 mg Injection.

Breastfeeding

Not known

The excretion of Cyramza 100 mg Injection in human milk remains uncertain. It is expected that excretion in milk and oral absorption will be minimal. Due to the potential risk to breastfeeding infants, it is recommended that breastfeeding be discontinued during treatment with Cyramza 100 mg and for at least three months after the remaining dose.

Driving

Unsafe

Cyramza 100 mg Injection has no or negligible effect on the ability to drive or use machinery. If patients experience symptoms that affect their ability to concentrate and react, it is recommended that they do not drive or use machinery until the effects have subsided.